FIELD: medicine, particularly, intensive therapy. SUBSTANCE: method includes, in acute period, hemofiltration against background of T-activin endotracheal inhalation for 10 min with interval of 3 h, during 7-12 days. As a result, actively removed from blood are biologically active substance with mean molecular weight; with no development of immunodeficiency that reduces frequency of development of pulmonary complications. EFFECT: higher efficiency of treatment.
